CLINICAL_TRIALS
trial_result
· 2022-05-23
Clinical Trial Update: PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization [Phase 3]
Summary
Phase 3 trial update on prevention of contrast-induced nephropathy using urine alkalinization has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: G. d'Annunzio University | Conditions: Acute Kidney Injury, Contrast Media Reaction | Phase 3 | Status: COMPLETED